Scarica l'app Stockscreener
50.26
0.98%
0.49
Dopo l'orario di chiusura:
50.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$49.77
Aprire:
$49.72
Volume 24 ore:
899.00K
Relative Volume:
0.93
Capitalizzazione di mercato:
$2.42B
Reddito:
$1.35B
Utile/perdita netta:
$163.34M
Rapporto P/E:
15.34
EPS:
3.2763
Flusso di cassa netto:
$189.17M
1 W Prestazione:
+2.89%
1M Prestazione:
+0.62%
6M Prestazione:
-12.09%
1 anno Prestazione:
-33.82%
Intervallo 1D:
$49.24
$50.67
Intervallo di 1 settimana:
$48.55
$50.67
Portata 52W:
$47.31
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Nome
Haemonetics Corp
Settore
Industria
Telefono
(781) 848-7100
Indirizzo
125 SUMMER STREET, BOSTON, MA
Confronta HAE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
50.26 | 2.40B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
128.54 | 222.13B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
99.24 | 144.89B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
374.42 | 141.17B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.78 | 121.91B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
74.64 | 42.65B | 5.69B | 1.41B | 577.90M | 6.9828 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Reiterato | Barrington Research | Outperform |
| 2025-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-06-26 | Iniziato | Robert W. Baird | Outperform |
| 2025-02-07 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Iniziato | JP Morgan | Overweight |
| 2024-11-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Iniziato | CL King | Buy |
| 2024-09-11 | Iniziato | BofA Securities | Neutral |
| 2024-09-10 | Iniziato | BTIG Research | Buy |
| 2024-06-12 | Aggiornamento | Needham | Hold → Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-01-27 | Downgrade | Needham | Buy → Hold |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Ripresa | Raymond James | Outperform |
| 2021-06-17 | Iniziato | Citigroup | Buy |
| 2021-05-14 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Iniziato | Needham | Buy |
| 2019-08-07 | Reiterato | Barrington Research | Outperform |
| 2019-05-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Reiterato | Barrington Research | Outperform |
| 2018-08-09 | Reiterato | Barrington Research | Outperform |
| 2018-02-07 | Reiterato | Barrington Research | Outperform |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Reiterato | Barrington Research | Outperform |
| 2017-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Reiterato | The Benchmark Company | Hold |
| 2016-09-20 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Downgrade | Sidoti | Buy → Neutral |
| 2016-08-02 | Reiterato | Jefferies | Buy |
| 2016-08-02 | Reiterato | The Benchmark Company | Hold |
Mostra tutto
Haemonetics Corp Borsa (HAE) Ultime notizie
What drives Haemonetics Corporation stock priceSmall Cap Stock Opportunities & Discover Top Gainers in Every Sector - earlytimes.in
How Will Weak Organic Sales Shape Haemonetics’ (HAE) Growth Strategy and Future Outlook? - Yahoo Finance
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
Assessing Haemonetics After Recent Regulatory Approval and a 34% Decline in 2025 - Yahoo Finance
How Do Investors Really Feel About Haemonetics Corp? - Sahm
Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know - Yahoo Finance
Nov 6, 2025: Haemonetics to Publish Q2 FY2026 Results at 6:00 AM ET — Investor Call 8:00 AM ET - Stock Titan
Haemonetics (NYSE:HAE) Receives Hold (C-) Rating from Weiss Ratings - MarketBeat
FY2028 EPS Estimates for Haemonetics Cut by Zacks Research - MarketBeat
Q1 EPS Estimates for Haemonetics Cut by Zacks Research - Defense World
Citigroup Lowers Price Target for Haemonetics (HAE) to $64.00 | - GuruFocus
Q1 EPS Estimates for Haemonetics Decreased by Zacks Research - MarketBeat
How Haemonetics Corporation stock responds to bond marketMarket Movement Recap & Low Risk Investment Opportunities - newser.com
Hunter Perkins Capital Management LLC Acquires Shares of 7,100 Haemonetics Corporation $HAE - MarketBeat
Is Haemonetics Corporation HAZ a good long term investmentTechnical Resistance Breaks & High Return Trading Plans - earlytimes.in
What analysts say about Launch Two Acquisition Corp stockEarnings Per Share Trends & Affordable Investment Portfolio - earlytimes.in
What analysts say about Haemonetics Corporation stockLarge Cap Stability Picks & Accelerated Capital Growth - earlytimes.in
Why Haemonetics Corporation (HAZ) stock stays on buy listsJuly 2025 Rallies & Safe Capital Allocation Plans - newser.com
Can trapped investors hope for a rebound in Haemonetics CorporationRate Hike & Growth Oriented Trading Recommendations - newser.com
What the Recent FDA Plasma Guidance Means for Haemonetics Investors in 2025 - simplywall.st
Haemonetics (NYSE:HAE) Reaches New 12-Month LowHere's What Happened - MarketBeat
How to forecast Haemonetics Corporation trends using time seriesTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Haemonetics (HAE) Undervalued? A Fresh Look at the Company’s Current Valuation - simplywall.st
How Haemonetics Corporation (HAZ) stock reacts to weak economyQuarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
Why analysts recommend Haemonetics Corporation (HAZ) stockJuly 2025 Outlook & Fast Entry High Yield Tips - newser.com
Haemonetics (HAE): Evaluating Valuation After Recent Share Price Weakness and Continued Earnings Growth - Yahoo Finance
Is Haemonetics Corporation (HAZ) stock a buy before earnings resultsMarket Growth Summary & Capital Protection Trading Alerts - newser.com
Published on: 2025-10-01 03:46:03 - newser.com
What technical patterns form on Haemonetics Corporation stock chartsGap Down & Entry and Exit Point Strategies - newser.com
Haemonetics Corporation stock volume spike explained2025 Market Overview & AI Enhanced Execution Alerts - newser.com
Exit strategy if you’re trapped in Haemonetics Corporation2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
How to use Fibonacci retracement on Haemonetics Corporation2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com
Published on: 2025-09-27 20:13:44 - newser.com
Real time breakdown of Haemonetics Corporation stock performanceBuy Signal & Verified Short-Term Plans - newser.com
Published on: 2025-09-26 12:26:45 - newser.com
Will Haemonetics Corporation stock keep outperforming rivalsWeekly Investment Summary & Growth Oriented Trading Recommendations - The British Mountaineering Council
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know - Yahoo Finance
Haemonetics (NYSE:HAE) Given Outperform Rating at Barrington Research - Defense World
Haemonetics (NYSE:HAE) Earns "Outperform" Rating from Barrington Research - MarketBeat
Haemonetics (HAE) Maintains Rating with Barrington Research | HA - GuruFocus
Is Haemonetics Corporation building a consolidation baseEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
Haemonetics Corp Azioni (HAE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):